213 related articles for article (PubMed ID: 12852701)
1. Trandolapril: a newer angiotensin-converting enzyme inhibitor.
Guay DR
Clin Ther; 2003 Mar; 25(3):713-75. PubMed ID: 12852701
[TBL] [Abstract][Full Text] [Related]
2. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
Muijsers RB; Curran MP; Perry CM
Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
[TBL] [Abstract][Full Text] [Related]
3. Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders.
Peters DC; Noble S; Plosker GL
Drugs; 1998 Nov; 56(5):871-93. PubMed ID: 9829159
[TBL] [Abstract][Full Text] [Related]
4. The fixed combination of verapamil SR/trandolapril.
Widimský J
Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
[TBL] [Abstract][Full Text] [Related]
5. Fixed combination verapamil SR/trandolapril.
Dooley M; Goa KL
Drugs; 1998 Nov; 56(5):837-44; discussion 845-6. PubMed ID: 9829157
[TBL] [Abstract][Full Text] [Related]
6. Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension.
Wiseman LR; McTavish D
Drugs; 1994 Jul; 48(1):71-90. PubMed ID: 7525196
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Holzgreve H; Nakov R; Beck K; Janka HU
Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
[TBL] [Abstract][Full Text] [Related]
8. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists.
Karlberg BE; Andrup M; Odén A
Blood Press; 2000; 9(2-3):140-5. PubMed ID: 10855738
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
[TBL] [Abstract][Full Text] [Related]
11. Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group).
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Pedersen-Bjergaard O
J Hypertens Suppl; 1997 Mar; 15(2):S119-22. PubMed ID: 9218208
[TBL] [Abstract][Full Text] [Related]
12. Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension.
Reynolds NA; Wagstaff AJ; Keam SJ
Drugs; 2005; 65(13):1893-914. PubMed ID: 16114984
[TBL] [Abstract][Full Text] [Related]
13. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
Messerli F; Frishman WH; Elliott WJ
Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
[TBL] [Abstract][Full Text] [Related]
14. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group.
DeQuattro V; Lee D
Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group.
DeQuattro V; Lee D; Messerli F
Clin Exp Hypertens; 1997 Apr; 19(3):373-87. PubMed ID: 9107443
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of the combination of verapamil and trandolapril.
Holzgreve H
J Hypertens Suppl; 1997 Mar; 15(2):S51-3. PubMed ID: 9218199
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension.
Cifková R; Nakov R; Novozámská E; Hejl Z; Petrzílková Z; Poledne R; Stávek P; Compagnone D
J Hum Hypertens; 2000 Jun; 14(6):347-54. PubMed ID: 10878692
[TBL] [Abstract][Full Text] [Related]
18. Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
Hansen JF
J Hypertens Suppl; 1998 Jan; 16(1):S71-4. PubMed ID: 9534101
[TBL] [Abstract][Full Text] [Related]
19. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Pedersen-Bjergaard O; Mortensen LS
Am J Cardiol; 1997 Mar; 79(6):738-41. PubMed ID: 9070551
[TBL] [Abstract][Full Text] [Related]
20. The treatment of severe hypertension with trandolapril, verapamil, and hydrochlorothiazide. Trandolapril/Verapamil Multicenter Study Group.
Punzi HA; Novrit BA
J Hum Hypertens; 1997 Aug; 11(8):477-81. PubMed ID: 9322827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]